Dolasetron Mesylate
Who holds supplier records for Dolasetron Mesylate? 2 organisations hold a current record for Dolasetron Mesylate: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Dolasetron Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/dolasetron-mesylate
Reading the evidence
- 2 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
2 of the 2 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (2)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dolasetron Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 24794 · latest filing Mar 2011
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 24145, 33211 · latest filing Sept 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Dolasetron Mesylate are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 24531 · filed Jan 2011
- Spain · Inactive DMF 21852 · filed Jul 2008
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dolasetron Mesylate is a serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dolasetron Mesylate?
2 organisations hold an active US FDA Type II Drug Master File or a CEP for Dolasetron Mesylate: Emcure Pharmaceuticals Limited (India) and USV PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dolasetron Mesylate Drug Master Files are active?
Emcure Pharmaceuticals Limited (DMF 24794) and USV PRIVATE LTD (DMF 24145, 33211). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dolasetron Mesylate records mean?
2 organisations have only inactive Type II DMFs for Dolasetron Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Dolasetron Mesylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dolasetron Mesylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.